- Report
- October 2024
- 74 Pages
Global
From €3500EUR$3,980USD£3,098GBP
Connective Tissue Growth Factor (CTGF) is a protein involved in the regulation of cell growth and differentiation. It is a key component of the extracellular matrix and is involved in the development of endocrine and metabolic disorders. CTGF is involved in the regulation of glucose and lipid metabolism, and is also involved in the regulation of insulin sensitivity. It is also involved in the regulation of bone and cartilage formation, and in the regulation of wound healing.
CTGF is a promising target for the development of drugs for endocrine and metabolic disorders. Several companies are developing CTGF-based therapies for the treatment of diabetes, obesity, and other metabolic disorders. These include Novo Nordisk, Sanofi, and Merck. Other companies such as Amgen, Pfizer, and Eli Lilly are also researching CTGF-based therapies for the treatment of endocrine and metabolic disorders. Show Less Read more